These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 9239444

  • 1. Effect of the haloperidol tetrahydropyridine metabolite 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6- tetrahydropyridine on dopamine receptor and transporter binding. A nonhuman primate 123I-iodobenzamide and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane single photon emission computed tomographic study.
    Oliver DW, Dormehl IC, Van der Schyf CJ, Neumeyer JL, Hugo N, Keeve R, Rossouw NT, Müller-Gärtner HW, Castagnoli N.
    Arzneimittelforschung; 1997 Jun; 47(6):692-9. PubMed ID: 9239444
    [Abstract] [Full Text] [Related]

  • 2. Long-term treatment with the tetrahydropyridine analog (HPTP) of haloperidol influences dopamine ligand binding in baboon brain. An [123I]iodobenzamide (IBZM) SPECT study.
    Van der Schyf CJ, Dormehl IC, Oliver DW, Hugo N, Keeve R, Müller-Gärtner HW, Pond SM, Castagnoli N.
    Brain Res Mol Brain Res; 1996 Dec 31; 43(1-2):251-8. PubMed ID: 9037540
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons.
    Dresel SH, Kung MP, Huang XF, Plössl K, Hou C, Meegalla SK, Patselas G, Mu M, Saffer JR, Kung HF.
    J Nucl Med; 1999 Apr 31; 40(4):660-6. PubMed ID: 10210226
    [Abstract] [Full Text] [Related]

  • 4. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T.
    J Nucl Med; 2000 Jan 31; 41(1):36-44. PubMed ID: 10647603
    [Abstract] [Full Text] [Related]

  • 5. Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates.
    Scanley BE, al-Tikriti MS, Gandelman MS, Laruelle M, Zea-Ponce Y, Baldwin RM, Zoghbi SS, Hoffer PB, Charney DS, Wang S.
    Eur J Nucl Med; 1995 Jan 31; 22(1):4-11. PubMed ID: 7698153
    [Abstract] [Full Text] [Related]

  • 6. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
    Wenning GK, Donnemiller E, Granata R, Riccabona G, Poewe W.
    Mov Disord; 1998 May 31; 13(3):438-45. PubMed ID: 9613734
    [Abstract] [Full Text] [Related]

  • 7. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
    Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, Sybirska EH, Zimmermann RC, Wisniewski G, Neumeyer JL.
    Synapse; 1993 Apr 31; 13(4):295-309. PubMed ID: 7683143
    [Abstract] [Full Text] [Related]

  • 8. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG, Müller TT, Zander C, Kuhn W, Farahati J, Reiners C, Coenen HH.
    J Investig Med; 1997 Oct 31; 45(8):448-52. PubMed ID: 9394097
    [Abstract] [Full Text] [Related]

  • 9. Iodine-123 labelled N-(2-fluoroethyl)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain.
    Kuikka JT, Akerman K, Bergström KA, Karhu J, Hiltunen J, Haukka J, Heikkinen J, Tiihonen J, Wang S, Neumeyer JL.
    Eur J Nucl Med; 1995 Jul 31; 22(7):682-6. PubMed ID: 7498231
    [Abstract] [Full Text] [Related]

  • 10. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A, Gandelman MS, DeErausquin GA, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Laruelle M, Charney DS, Hoffer PB, Neumeyer JL, Innis RB.
    J Nucl Med; 1996 Jul 31; 37(7):1129-33. PubMed ID: 8965183
    [Abstract] [Full Text] [Related]

  • 11. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB.
    J Nucl Med; 1998 Sep 31; 39(9):1500-8. PubMed ID: 9744331
    [Abstract] [Full Text] [Related]

  • 12. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
    Donnemiller E, Heilmann J, Wenning GK, Berger W, Decristoforo C, Moncayo R, Poewe W, Ransmayr G.
    Eur J Nucl Med; 1997 Mar 31; 24(3):320-5. PubMed ID: 9143472
    [Abstract] [Full Text] [Related]

  • 13. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S, Tatsch K, Dähne I, Mager T, Scherer J, Hahn K.
    J Nucl Med; 1998 Jul 31; 39(7):1138-42. PubMed ID: 9669383
    [Abstract] [Full Text] [Related]

  • 14. Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain.
    Kuikka JT, Bergström KA, Ahonen A, Hiltunen J, Haukka J, Länsimies E, Wang S, Neumeyer JL.
    Eur J Nucl Med; 1995 Apr 31; 22(4):356-60. PubMed ID: 7607268
    [Abstract] [Full Text] [Related]

  • 15. [Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms].
    Bettin S, Kämpfer I, Seese A, Schäfer A, Reuter M, Lössner J, Dietrich J, Wagner A, Knapp WH.
    Nuklearmedizin; 1997 Aug 31; 36(5):167-72. PubMed ID: 9380528
    [Abstract] [Full Text] [Related]

  • 16. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB, Malison RT, al-Tikriti M, Hoffer PB, Sybirska EH, Seibyl JP, Zoghbi SS, Baldwin RM, Laruelle M, Smith EO.
    Synapse; 1992 Mar 31; 10(3):177-84. PubMed ID: 1532675
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the dopamine transporter in nonhuman primate brain: homogenate binding, whole body imaging, and ex vivo autoradiography using [125I] and [123I]IPCIT.
    al-Tikriti MS, Zea-Ponce Y, Baldwin RM, Zoghbi SS, Laruelle M, Seibyl JP, Giddings SS, Scanley BE, Charney DS, Hoffer PB.
    Nucl Med Biol; 1995 Jul 31; 22(5):649-58. PubMed ID: 7581176
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI.
    Baldwin RM, Zea-Ponce Y, Zoghbi SS, Laurelle M, al-Tikriti MS, Sybirska EH, Malison RT, Neumeyer JL, Milius RA, Wang S.
    Nucl Med Biol; 1993 Jul 31; 20(5):597-606. PubMed ID: 8358345
    [Abstract] [Full Text] [Related]

  • 19. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.
    Asenbaum S, Brücke T, Pirker W, Podreka I, Angelberger P, Wenger S, Wöber C, Müller C, Deecke L.
    J Nucl Med; 1997 Jan 31; 38(1):1-6. PubMed ID: 8998140
    [Abstract] [Full Text] [Related]

  • 20. Dopamine receptor binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)- 4-oxobutyl]-1,2,3,6-tetrahydropyridine (HPTP), an intermediate metabolite of haloperidol.
    Brand L, Oliver DW, van der Schyf CJ, Pond SM, Castagnoli N.
    Life Sci; 1996 Jan 31; 59(10):815-20. PubMed ID: 8761315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.